LAV Biosciences Fund V, L.P.

TERN

LAV Biosciences Fund V, L.P. serves as 10% Owner at Terns Pharmaceuticals, Inc. (TERN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$8.25M

Net Position

Net Seller

$8.25M

Companies Traded

TERN

Active Period

Nov 2022

1 total trades

Most Recent

Sell TERN

Nov 28, 2022 · $8.25M

LAV Biosciences Fund V, L.P.'s Insider Trading at Terns Pharmaceuticals, Inc. (TERN)

Buys

0 · $0.00

Sells

1 · $8.25M

Total Shares Bought

Total Shares Sold

1,500,000

TERN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 28, 2022	Sell	1,500,000	$5.50	$8.25M	1,059,523

Related Insiders

Amy L. Burroughs

director, officer: Chief Executive Officer

TERNSell · Mar 17, 2026

Emil Kuriakose

officer: Chief Medical Officer

TERNSell · Jan 6, 2026

Jill M. Quigley

TERNSell · Nov 5, 2025

Andrew Gengos

Chief Financial Officer

TERNBuy · Jun 30, 2025

Explore More Insider Trading Data

TERN Insider Trading Activity

View all insider trades at Terns Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity